Alta Capital Management LLC Amgen Inc Transaction History

Alta Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $776,206 - $952,511	-3,924 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $357,554 - $474,215	1,962 Added 100.0%	3,924 $795,000
Q1 2018 Apr 06, 2018	SELL	$169.43 - $198.0 $192,133 - $224,532	-1,134 Reduced 36.63%	1,962 $334,000
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $517,929 - $591,336	3,096	3,096 $577,000

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Alta Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alta Capital Management LLC with notifications on news.